Dashboard
High Management Efficiency with a high ROE of 32.33%
Company has a low Debt to Equity ratio (avg) at times
Poor long term growth as Operating profit has grown by an annual rate 13.19% of over the last 5 years
Flat results in May 25
With ROE of 31.15%, it has a fair valuation with a 10.45 Price to Book Value
Total Returns (Price + Dividend) 
Karooooo Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
Is Karooooo Ltd. overvalued or undervalued?
As of 21 November 2025, the valuation grade for Karooooo Ltd. moved from very attractive to attractive. The company appears to be overvalued based on its current metrics. The P/E ratio stands at 34, significantly higher than the peer average of approximately 30.12, while the EV to EBITDA ratio is 16.34, compared to the peer average of 14.77. Additionally, the PEG ratio is 1.00, indicating that the growth expectations may not justify the current price. In comparison to its peers, HealthStream, Inc. has a P/E ratio of 40.95, while Planet Labs PBC shows a negative P/E, highlighting the varied valuation landscape within the industry. Over the past year, Karooooo Ltd. has returned 5.38%, which lags behind the S&P 500's return of 11.00%, further suggesting that the stock may not be a compelling investment at its current valuation....
Read MoreIs Karooooo Ltd. overvalued or undervalued?
As of 24 October 2025, the valuation grade for Karooooo Ltd. has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company appears to be undervalued, supported by a P/E ratio of 34, an EV to EBITDA of 16.34, and a PEG ratio of 1.00, which suggests that the stock is reasonably priced relative to its growth expectations. In comparison, HealthStream, Inc. has a higher P/E ratio of 40.95, while Planet Labs PBC shows a negative P/E, highlighting Karooooo's relative strength in valuation metrics. Karooooo's recent performance shows a 1-year return of 19.99%, outperforming the S&P 500's return of 16.90%, and a 3-year return of 97.49% compared to the S&P 500's 78.85%. This strong performance reinforces the notion that the stock is undervalued, as it has delivered superior returns relative to the benchmark....
Read MoreIs Karooooo Ltd. overvalued or undervalued?
As of 24 October 2025, the valuation grade for Karooooo Ltd. moved from attractive to very attractive. The company appears to be undervalued based on its current metrics. Key ratios include a P/E ratio of 34, an EV to EBITDA of 16.34, and a PEG ratio of 1.00, which suggest that the stock is priced favorably relative to its growth potential. In comparison to peers, Karooooo Ltd. has a more favorable valuation profile than HealthStream, Inc., which has a P/E of 40.95, and significantly better than the risky peers like Planet Labs PBC and Couchbase, Inc. Additionally, Karooooo's recent stock performance shows a 1-year return of 19.99%, outperforming the S&P 500's return of 16.90%, reinforcing the notion that the stock is undervalued....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Feb 2025
Shareholding Compare (%holding) 
Foreign Institutions
Held in 6 Schemes (0.64%)
Held by 17 Foreign Institutions (2.99%)
Quarterly Results Snapshot (Consolidated) - May'25 - QoQ
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Feb'25
YoY Growth in year ended Feb 2025 is 11.07% vs 7.24% in Feb 2024
YoY Growth in year ended Feb 2025 is 27.30% vs 10.71% in Feb 2024






